Chief Scientific Officer - Early Drug Development

Benefits

Qualifications

• •Possess a doctoral degree in life sciences or a related medical field
• •Over 20 years of research and development experience in multinational pharmaceutical companies or top biotech firms
• •Profound biological knowledge in core disease areas such as oncology, metabolism, autoimmunity, or the central nervous system
• •Deep understanding of emerging therapeutic modalities
• •Complete R&D success experience from the laboratory to the clinic
• •Led and advanced at least five innovative drug projects into the clinical stage and successfully completed POC
• •Outstanding scientific insight and strategic decision-making ability to predict industry trends and transform them into the company's R&D advantages
• •Outstanding leadership with the charisma and influence to inspire, attract, and retain top scientific talents
• •5 more items(s)

Responsibilities

• •The Chief Scientific Officer - Early Drug Development will formulate and lead the company's global early-stage R&D strategy, establishing the R&D roadmap from target validation to proof-of-concept (POC)
• •Lead the drug chemistry team and the biology team
• •Establish a global R&D layout and talent echelon for innovative drugs of Qilu
• •Plan and make decisions regarding the innovative drug pipeline, including cutting-edge technology fields such as small molecules, large molecules, ADCs, and small nucleic acids
• •Establish strategic partnerships with the global academic community, research institutions, and biotechnology companies to introduce cutting-edge technologies
• •Research on leadership mechanisms and formulate biomarker strategies to provide a solid scientific basis for R&D decisions
• •3 more items(s)